Search alternatives:
mean decrease » a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
mg decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
5 mg » 5 mm (Expand Search)
mean decrease » a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
mg decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
5 mg » 5 mm (Expand Search)
-
8841
Table_3_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.doc
Published 2023“…</p>Methods<p>We isolated Streptomyces species from soil samples and identified the most active strains with antimicrobial activity. …”
-
8842
Table_4_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.doc
Published 2023“…</p>Methods<p>We isolated Streptomyces species from soil samples and identified the most active strains with antimicrobial activity. …”
-
8843
Image_4_Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.jpeg
Published 2023“…</p>Methods<p>We isolated Streptomyces species from soil samples and identified the most active strains with antimicrobial activity. …”
-
8844
ONO-1301 enhanced SDF-1 secretion and BMC migration via SDF-1/CXCR4 signaling after MI.
Published 2013“…When BMCs treated with AMD were injected, the BMC accumulation decreased in the 100 mg/Kg ONO-1301-treated infarcted heart compared with the untreated-BMC-injected heart (0 mg/Kg, n = 4; 10 mg/Kg, n = 8; 100 mg/Kg, n = 5; 100 mg/Kg+AMD3100, n = 4; *<i>P</i><0.05 vs. 0 mg/Kg, †<i>P</i><0.05 vs. 10 mg/Kg, ‡<i>P</i><0.05 vs. 100 mg/Kg).…”
-
8845
PA5369 Is Involved in Adhesiveness and Ability of MDR25 and MPAO1 to Disrupt Epithelial Integrity
Published 2008“…<div><p>(A) Anti-PA5369 antibodies decrease the adhesiveness of strain MDR25 to Caco-2 monolayers<i>.…”
-
8846
DataSheet_1_TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia.pdf
Published 2021“…We documented a progressive decrease of CD3+CD4+IL-4+ T cells (Th2), that was significant at M8 and at M12 (p=0.019, p=0.002), a relative increase in the CD3+CD4+IFNγ+ T cells (Th1) and a decrease of CD3+CD4+IL-17+ (Th17) cells that was maintained up to M18 (M8 vs D0 p=0.003, M12 vs D0 p=0.003, M18 vs D0 p=0.004) of ibrutinib treatment. …”
-
8847
Mechanism of insulin resistance in a rat model of kidney disease and the risk of developing type 2 diabetes
Published 2017“…Further, glucose tolerance tests indicated an increase of 25% in glycemia in chronic kidney disease rats (p<0.0001) as compared to controls whereas insulin levels remained unchanged. We also observed modulation of glucose transporters expression in several tissues such as the liver (decrease of ≈40%, p≤0.01) and muscles (decrease of ≈29%, p≤0.05). …”
-
8848
Image2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg
Published 2024“…</p>Objective<p>The purpose of this study was to analyze the effect of omalizumab on peripheral blood lymphocyte subpopulations in patients with CSU in order to identify potential biomarkers of treatment response.</p>Methods<p>We analyzed 71 patients with CSU [33 under omalizumab and 38 under non-immunomodulatory drugs (treated with antihistamines; NID)] and 50 healthy controls. …”
-
8849
Image1_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg
Published 2024“…</p>Objective<p>The purpose of this study was to analyze the effect of omalizumab on peripheral blood lymphocyte subpopulations in patients with CSU in order to identify potential biomarkers of treatment response.</p>Methods<p>We analyzed 71 patients with CSU [33 under omalizumab and 38 under non-immunomodulatory drugs (treated with antihistamines; NID)] and 50 healthy controls. …”
-
8850
Table4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx
Published 2024“…</p>Objective<p>The purpose of this study was to analyze the effect of omalizumab on peripheral blood lymphocyte subpopulations in patients with CSU in order to identify potential biomarkers of treatment response.</p>Methods<p>We analyzed 71 patients with CSU [33 under omalizumab and 38 under non-immunomodulatory drugs (treated with antihistamines; NID)] and 50 healthy controls. …”
-
8851
Image3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf
Published 2024“…</p>Objective<p>The purpose of this study was to analyze the effect of omalizumab on peripheral blood lymphocyte subpopulations in patients with CSU in order to identify potential biomarkers of treatment response.</p>Methods<p>We analyzed 71 patients with CSU [33 under omalizumab and 38 under non-immunomodulatory drugs (treated with antihistamines; NID)] and 50 healthy controls. …”
-
8852
Table3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx
Published 2024“…</p>Objective<p>The purpose of this study was to analyze the effect of omalizumab on peripheral blood lymphocyte subpopulations in patients with CSU in order to identify potential biomarkers of treatment response.</p>Methods<p>We analyzed 71 patients with CSU [33 under omalizumab and 38 under non-immunomodulatory drugs (treated with antihistamines; NID)] and 50 healthy controls. …”
-
8853
Image4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf
Published 2024“…</p>Objective<p>The purpose of this study was to analyze the effect of omalizumab on peripheral blood lymphocyte subpopulations in patients with CSU in order to identify potential biomarkers of treatment response.</p>Methods<p>We analyzed 71 patients with CSU [33 under omalizumab and 38 under non-immunomodulatory drugs (treated with antihistamines; NID)] and 50 healthy controls. …”
-
8854
Table2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx
Published 2024“…</p>Objective<p>The purpose of this study was to analyze the effect of omalizumab on peripheral blood lymphocyte subpopulations in patients with CSU in order to identify potential biomarkers of treatment response.</p>Methods<p>We analyzed 71 patients with CSU [33 under omalizumab and 38 under non-immunomodulatory drugs (treated with antihistamines; NID)] and 50 healthy controls. …”
-
8855
Table1_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx
Published 2024“…</p>Objective<p>The purpose of this study was to analyze the effect of omalizumab on peripheral blood lymphocyte subpopulations in patients with CSU in order to identify potential biomarkers of treatment response.</p>Methods<p>We analyzed 71 patients with CSU [33 under omalizumab and 38 under non-immunomodulatory drugs (treated with antihistamines; NID)] and 50 healthy controls. …”
-
8856
ELMO1 Is Upregulated in AML CD34+ Stem/Progenitor Cells, Mediates Chemotaxis and Predicts Poor Prognosis in Normal Karyotype AML
Published 2014“…Finally, ELMO1 depletion caused a marked decrease in SDF1-induced chemotaxis of leukemic cells. …”
-
8857
Supplementary file 1_Ivarmacitinib reduces the need for adding/escalating medications in moderate-to-severe rheumatoid arthritis patients: a post hoc analysis from a phase III tria...
Published 2025“…</p>Results<p>Ivarmacitinib 4 mg (7.4%) and 8 mg (5.3%) groups had significantly lower rates of adding/escalating medication compared to the placebo group (22.3%) within W24 (both P < 0.001). …”
-
8858
Image 1_Ivarmacitinib reduces the need for adding/escalating medications in moderate-to-severe rheumatoid arthritis patients: a post hoc analysis from a phase III trial.tif
Published 2025“…</p>Results<p>Ivarmacitinib 4 mg (7.4%) and 8 mg (5.3%) groups had significantly lower rates of adding/escalating medication compared to the placebo group (22.3%) within W24 (both P < 0.001). …”
-
8859
Comparison of Mycoplasma gallisepticum Infection in Different Samples and Ages of Chicken Breeder Flocks
Published 2021“…Also, 900 blood samples from the same 5 breeder flocks suffering from respiratory disease problems were tested by MG-ELISA. …”
-
8860
Effect of organic cultivation of rooibos tea plants (<i>Aspalathus linearis</i>) on soil nutrient status in Nieuwoudtville, South Africa
Published 2016“…Compared with the uncultivated plots, no measured soil nutrients including concentrations of phosphorus (P), exchangeable potassium (K), magnesium (Mg) and calcium (Ca), and soil carbon (C) decreased in cultivated plots over the five-year period of assessment. …”